Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA
- 329 Downloads
The objective of this study was to assess the differences in HPV-related knowledge, attitudes, and beliefs among African American and non-Hispanic white women and to determine their communication preferences for cancer-related information. Data was obtained from the National Cancer Institute’s (NCI) 2014 Health Interview National Trends Survey (HINTS), a cross-sectional survey of US adults 18 years of age or older. Descriptive statistics, bivariate, and multivariate logistic regression were used to identify differences in awareness and knowledge. Data was collected in 2014 and analyzed in 2016. HPV awareness (71 vs. 77%) and knowledge that HPV causes cervical cancer (64 vs. 81%) were significantly lower among blacks. Additionally, there were significant disparities in awareness of the HPV vaccine (66 vs. 79%), with only 25% of Black women indicating that they or a family member was recommended the HPV vaccine by a health care professional. There were also differences in cancer communication preferences. Blacks were more likely than Whites to trust cancer information from family (OR 2.7, confidence interval [CI] 0.725–10.048), television (OR 3.0, 95% [CI] 0.733–12.296), government health agencies (OR 5.8, [CI] 0.639–52.818), and religious organizations (OR 6.4, 95% [CI] 1.718–23.932). Study results indicate that racial/ethnic differences exist in HPV knowledge/awareness and cancer communication preferences. These results highlight the need to increase HPV prevention and education efforts using methods that are tailored to Black women. To address HPV/cervical cancer disparities, future interventions should utilize preferred communication outlets to effectively increase HPV knowledge and vaccine awareness.
KeywordsCervical cancer prevention Health disparities Health education Human papillomavirus HPV
Compliance with Ethical Standards
Conflict of Interest
This study was supported by Award Number U54 CA118638 from the National Institutes of Health. The National Institutes of Health did not have any role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.
No financial disclosures were reported by the authors of this paper.
- 1.American Cancer Society. (2016) Cancer facts & figures. 2016. American Cancer Society, AtlantaGoogle Scholar
- 3.American Cancer Society (2016) Cancer facts & figures for African Americans 2016–2018. American Cancer Society, AtlantaGoogle Scholar
- 4.Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19. doi: 10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f CrossRefGoogle Scholar
- 6.Centers for Disease Control and Prevention (2016) Genital HPV infection—fact sheet. http://www.cdc.gov/STD/HPV/STDFact-HPV.htm. Accessed 14 July 2016
- 8.Centers for Disease Control and Prevention (2010) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 59(20):626–629Google Scholar
- 9.Petrosky E, Bocchini JA, Hariri S et al (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep 64(11):300–304Google Scholar
- 11.Office of Disease Prevention and Health Promotion (2015) Immunization and infectious diseases. Healthy people 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases. Accessed 14 July 2016
- 13.Beavis AL, Levinson KL. 2016 Preventing cervical cancer in the United States: barriers and resolutions for HPV vaccination. Front. Oncol. 6(19). doi: 10.3389/fonc.2016.00019.
- 21.Friedman AL, Shepeard H (2007) Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behavior 34(3):471–485. doi: 10.1097/lgt.0b013e318168e607 CrossRefGoogle Scholar
- 22.National Cancer Institute (2015) Health information national trends survey 4 (HINTS 4) cycle 4 methodology report. http://hints.cancer.gov/docs/Instruments/HINTS-FDA_Methodology_Report.pdf. Accessed 18 July 2016